Which of the following helps to prevent premature LH surge during oocyte retrieval for in vitro fertilization
**Core Concept**
The premature luteinizing hormone (LH) surge during oocyte retrieval for in vitro fertilization (IVF) can compromise the quality and quantity of oocytes obtained. To prevent this, medications are used to suppress the LH surge, allowing for optimal oocyte maturation and retrieval.
**Why the Correct Answer is Right**
GnRH agonists, such as leuprolide acetate, are commonly used to prevent premature LH surge during IVF. They work by initially stimulating the pituitary gland to release gonadotropins, including LH, and then downregulating the GnRH receptors, leading to a decrease in LH secretion. This suppression of LH surge allows for controlled ovarian stimulation and optimal oocyte maturation.
**Why Each Wrong Option is Incorrect**
**Option A:** GnRH antagonists, such as ganirelix, can also suppress LH surge but are typically used in conjunction with GnRH agonists to prevent premature LH surge. They work by competitively inhibiting GnRH receptors.
**Option B:** Clomiphene citrate is a selective estrogen receptor modulator (SERM) that stimulates ovulation but does not prevent premature LH surge.
**Option C:** Progesterone does not affect LH secretion and is used primarily for luteal phase support in IVF cycles.
**Clinical Pearl / High-Yield Fact**
GnRH agonists can cause an initial flare effect, which can stimulate LH release, so they should be started 2-3 days before ovarian stimulation to prevent premature LH surge.
**Correct Answer: C. Progesterone does not affect LH secretion and is used primarily for luteal phase support in IVF cycles.